Mindfulness yoga is a safe and effective treatment option for patients with mild-to-moderate Parkinson disease to help them manage stress and symptoms.
Kyowa Hakko Kirin announced that the FDA has accepted the resubmitted NDA for istradefylline for use as adjunctive treatment to levodopa/carbidopa in adults with Parkinson disease experiencing OFF episodes.
Cognitive behavioral therapy may improve a diverse array of depressive symptoms in patients with Parkinson disease.
In patients with Parkinson disease psychosis, treatment with pimavanserin has a lower risk for mortality compared with quetiapine or combination therapy.
The authors suggest that anxiety should be routinely evaluated in patients with Parkinson disease who experience freezing of gait.
As the neurodegenerative processes of Alzheimer disease and Parkinson disease are different, early cognitive impairment also present differently in these diseases.